SARS coronavirus: a new challenge for prevention and therapy.
about
The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike proteinBiochip sensors for the rapid and sensitive detection of viral diseaseTime course and cellular localization of SARS-CoV nucleoprotein and RNA in lungs from fatal cases of SARS.SARS molecular epidemiology: a Chinese fairy tale of controlling an emerging zoonotic disease in the genomics era.Molecular and biological characterization of human monoclonal antibodies binding to the spike and nucleocapsid proteins of severe acute respiratory syndrome coronavirus.Cynomolgus macaque as an animal model for severe acute respiratory syndrome.Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes miceDuration of antibody responses after severe acute respiratory syndromeCivets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates.Multiple organ infection and the pathogenesis of SARS.The spike protein of SARS-CoV--a target for vaccine and therapeutic development.Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site.Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodiesFalse-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based western blot assay were rectified by the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV.Protein-Protein Interactions of Viroporins in Coronaviruses and Paramyxoviruses: New Targets for Antivirals?Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV).Understanding Viral Transmission Behavior via Protein Intrinsic Disorder Prediction: CoronavirusesAnimal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association.Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice.Immunological characterization of the spike protein of the severe acute respiratory syndrome coronavirus.Generation and characterization of DNA vaccines targeting the nucleocapsid protein of severe acute respiratory syndrome coronavirus.Persistent replication of severe acute respiratory syndrome coronavirus in human tubular kidney cells selects for adaptive mutations in the membrane protein.Channel-Inactivating Mutations and Their Revertant Mutants in the Envelope Protein of Infectious Bronchitis Virus.The prevalence, origin, and prevention of six human coronaviruses.The epitope study on the SARS-CoV nucleocapsid protein.Traditional Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas, Cassia tora, and Taxillus chinensis inhibit SARS-CoV replicationEvaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors.Antibody to severe acute respiratory syndrome (SARS)-associated coronavirus spike protein domain 2 cross-reacts with lung epithelial cells and causes cytotoxicity.Lupus pneumonitis or severe acute respiratory syndrome?From SARS coronavirus to novel animal and human coronaviruses.Coronaviridae and SARS-associated coronavirus strain HSR1.Identification of SARS-COV spike protein-derived and HLA-A2-restricted human CTL epitopes by using a new muramyl dipeptidederivative adjuvant.Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis.siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.
P2860
Q24792382-7F7885EE-8EE0-4705-9302-3C34BB46B414Q24812397-33945963-90C2-495C-8CD8-03D12B00D03CQ25256694-57E9FD25-BE3C-485A-B10D-458F5C29C1B3Q30360085-36F3D3FD-809C-42E7-8659-95E17E8EE6EBQ33210858-1154C616-E4F0-4804-A222-19AD2F3095FDQ33239453-839F7F57-7380-4957-88B7-E1B0BC6B9908Q33696283-E4563793-01CB-4567-8BF0-58ACA816A92CQ33776548-54C9E54C-F2A4-42A8-8286-6BAE165F7369Q33781814-FA21563B-E34A-4890-9797-253B30550E57Q33988914-A021F9D4-296B-4857-B29B-E492B97AA1AAQ34015988-94C0FDFC-DA56-4FC2-816F-5530EC8A8866Q34152645-A9D0CD0E-4A37-41D6-99AE-2AFCF0BE3B6FQ34193942-3EC3D57A-F21F-4F0B-8E0B-7678F65C52AEQ34338054-9B87F6E6-F594-4B8A-981F-5D91547242EAQ34429423-3536FD14-29C0-4D79-BD82-5B2940FDB32FQ35808644-472F4EB5-E652-4EE1-A28D-01F9BC9E7DB9Q35998116-E530032A-6BBA-4860-8C7F-CA7F301F80D0Q36336728-718255F6-7A75-47AF-AAC1-8E79551289C0Q36447896-8A492255-EF2A-45D1-ABC0-E54DA6B34FD2Q36602721-308D38DA-F007-443C-9EE7-B0ED32474BFCQ37010921-617B76E0-0060-46E0-8FBF-9884020DBD57Q37421234-1314D77A-2654-4B62-A496-5D94201F68CDQ37423250-47DD97D2-4090-43A2-935F-984B1FD14D0FQ38610308-58429C9B-2D3E-4DC3-A3A9-7CC2B510AFB5Q39100395-E85F831B-4586-43E0-9CE0-08903365FE94Q39184006-226CB161-29DC-49C7-83FA-D9C7F8366D75Q39515561-697475CB-5B9E-40DF-B9D6-34FE8980C8F5Q39703230-A0B13F85-4368-47F4-84BB-4D0F5A6101D5Q40368906-FA27606F-C659-4C7B-BB07-B95D5A4D9273Q40393123-C23E82CC-96C0-4A9E-B7AE-5FFDE88C33A6Q40526502-C1FFECF4-62B9-4ABA-8869-A889DCF9122FQ42249851-1D833EC7-E471-4B68-B6FC-E2BF07619DDFQ42552025-368DA98A-FB54-40D1-8499-B0F4F007AE0DQ43105930-BD8E82C7-9829-4410-8819-6B05735D719CQ43232696-52F17B44-FF88-4AED-9235-F5FAAC0F3158Q45496781-CF5BCA1C-6F7D-44CC-9E74-81166E226B65
P2860
SARS coronavirus: a new challenge for prevention and therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
SARS coronavirus: a new challenge for prevention and therapy.
@ast
SARS coronavirus: a new challenge for prevention and therapy.
@en
type
label
SARS coronavirus: a new challenge for prevention and therapy.
@ast
SARS coronavirus: a new challenge for prevention and therapy.
@en
prefLabel
SARS coronavirus: a new challenge for prevention and therapy.
@ast
SARS coronavirus: a new challenge for prevention and therapy.
@en
P2860
P356
P1476
SARS coronavirus: a new challenge for prevention and therapy.
@en
P2860
P304
P356
10.1172/JCI18819
P407
P577
2003-06-01T00:00:00Z